POET Technologies - $3M+ Long-Term Bull Bet on AI Infrastructure Revolution!
$3M+ institutional whale spotted in POET options - significant institutional activity. Big money is positioning for AI infrastructure revolution with optical interposer technology. Fresh $75M capital raise completed today, stock up 27.7% YTD. Premium analysis reveals hidden gamma levels, production
π October 7, 2025 | π₯ Unusual Activity Detected
π― The Quick Take
Traders just committed $3.03M in bullish call positions on POET Technologies with heavy concentration on January 2027 LEAPS at the $10 strike! With POET trading at $8.77 (+27.7% YTD) and fresh off a record $75M capital raise completed today, smart money is positioning for explosive growth as the company transitions to commercial production in 2026. The gamma setup shows massive 7.10M resistance wall at $10, but that's exactly where the biggest bets are placed - with a bullish 42:1 call/put gamma ratio backing the move! Translation: This AI infrastructure play is heading for a major breakout as optical interposer technology becomes critical for next-gen data centers!
π Company Overview
POET Technologies Inc. (POET) is a design and development company offering:
- Market Cap: $578.8 Million
- Industry: Semiconductors - Optical Components
- Employees: 90
- Primary Business: High-speed optical engines, light source products, and custom optical modules for AI systems and hyperscale data centers using proprietary POET Optical Interposer technology
POET's platform allows seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques, solving critical bottlenecks in AI infrastructure connectivity.
π The Option Flow Breakdown
The Tape (October 7, 2025 @ Multiple Expirations):
| Time | Symbol | Side | Buy/Sell | Type | Expiration | Premium | Strike | Volume | OI | Size | Spot | Option Price |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14:32:39 | POET | MID | BUY | CALL | 2026-04-17 | $770K | $12 | 12K | 5.2K | 7,000 | $7.78 | $1.10 |
| 14:13:51 | POET | BID | SELL | CALL | 2025-10-17 | $374K | $7.5 | 14K | 280 | 3,400 | $7.98 | $1.10 |
| 14:13:51 | POET | MID | BUY | CALL | 2025-10-17 | $326K | $8 | 10K | 5.1K | 3,400 | $7.98 | $0.96 |
| 13:49:08 | POET | MID | BUY | CALL | 2027-01-15 | $168K | $10 | 2.1K | 52K | 959 | $7.46 | $1.75 |
| 13:46:23 | POET | MID | BUY | CALL | 2027-01-15 | $993K | $10 | 19K | 52K | 5,677 | $7.39 | $1.75 |
| 13:33:09 | POET | ASK | BUY | CALL | 2027-01-15 | $382K | $10 | 12K | 52K | 2,416 | $7.25 | $1.60 |
| 09:39:19 | POET | ASK | BUY | CALL | 2027-01-15 | $387K | $10 | 3.9K | 52K | 2,499 | $7.21 | $1.55 |
Total Premium: $3.03M in aggressive call buying (excluding the $374K sell) = Long-term bullish positioning
What This Actually Means
This is patient capital positioning for a multi-year growth story - not a quick flip! The traders:
- Commit $1.93M to January 2027 LEAPS at $10 strike (52K open interest shows massive conviction)
- Add $770K in April 2026 calls at $12 strike betting on 50%+ upside
- Layer in $326K of near-term October calls for immediate catalyst
- Create concentrated positioning at $10 strike showing confidence in commercial ramp
- Time perfectly after $75M capital raise announcement
Unusual Score: Highly unusual for POET - this represents significant institutional accumulation ahead of the production inflection point. The concentrated 52K open interest in January 2027 $10 LEAPS shows conviction in the multi-year growth story, not short-term speculation.
π Technical Setup / Chart Analysis
YTD Performance Chart
POET Technologies has delivered an impressive +27.7% YTD gain, significantly outperforming the broader market! The recent surge coincides with the company's transition from R&D to commercial production.
Key observations:
- Breakout pattern: Stock breaking above $7 resistance after consolidation
- Volume profile: Elevated buying on up days showing accumulation
- Current price: $8.77, near recent highs after $75M funding announcement
- Momentum: Strong uptrend since September following production order announcement
- Recent catalyst: $75M private placement closed October 7, 2025 - largest single investment!
Gamma-Based Support & Resistance Analysis
Current Price: $8.77
The gamma chart reveals a concentrated bullish setup with clear levels:
π Resistance Levels (Call Gamma Above Price):
- $9.00 - Immediate ceiling (Total gamma: 0.77M) - First technical barrier
- $10.00 - MAJOR WALL (Total gamma: 7.10M) - Where $1.93M in LEAPS are concentrated!
- $10.50 - Secondary barrier - Extended target for bulls
π΅ Support Levels (Put Gamma Below Price):
- $8.50 - Immediate floor (Total gamma: 0.04M) - Near-term support
- $8.00 - Strong support (Total gamma: 2.63M) - Significant gamma protection
- $7.50 - Deep safety net - Major downside protection level
Market Summary: Net GEX bias is BULLISH with total call gamma (16.12M) massively exceeding put gamma (0.38M) - a 42:1 ratio! This means:
- Strong institutional conviction via LEAPS positioning
- Market makers will support dips toward $8.00-8.50
- Breakout above $9.00 opens path to $10 LEAPS target
- The $10 resistance matches exactly where institutional money is betting with January 2027 calls!
β‘ Catalysts
Upcoming Events
Q3 2025 Earnings - November 12, 2025
- Analyst estimates: -$0.14 EPS, $400K revenue (Source: TipRanks)
- Key focus: Production ramp-up timeline and customer order updates
- Market expects update on $500K+ initial production order shipping timeline
Commercial Production Ramp-Up
- First production order exceeding $500K confirmed with optical engines scheduled to ship early 2026
- Production expected to scale to high volumes throughout 2026
- Critical transition from R&D company to revenue-generating business
Manufacturing Partnership Progress
- Globetronics and NationGate Solutions facilities in Malaysia actively qualifying 800G and 1.6T optical engines
- Capacity to meet projected demand of 20 million units per year for 400G and 800G modules
- Volume production timeline with Foxconn Interconnect Technology (FIT) targeted for H2 2025
Strategic Customer Announcements
- Lessengers partnership for 800G DR8 transceivers providing access to Chinese AI market
- Semtech collaboration on 1.6T receiver optical engines launched September 2025
- NTT Innovation Devices partnership for advanced AI mobile networking applications
Recently Completed
Record $75 Million Private Placement - October 7, 2025
- Largest single investment in company history closed today bringing total cash to over $150M
- Shares issued at $5.50 with warrants at C$9.78, showing institutional confidence
- Provides runway for commercial scaling through critical 2026 production phase
Industry Recognition
- "AI Hardware Innovation Award" at 2025 AI Breakthrough Awards for Teralightβ’ optical engine
- Nominated for "Most Innovative Hybrid PIC/Optical Integration Platform" at ECOC 2025
- Second consecutive year of major industry awards
Technology Validation
- Cost reduction of up to 70% versus conventional photonics solutions validated
- Wafer-level passive assembly eliminating costly active alignment procedures
- Platform supports 400G, 800G, and 1.6T data transmission speeds for next-gen AI applications
π― Price Targets & Probabilities
Using the gamma levels, catalyst timeline, and options positioning:
π Bull Case (40% chance)
Target: $10-12 by mid-2026
Catalysts:
- Breaks above $9.00 resistance opens path to $10.00 LEAPS target (7.10M gamma wall)
- Q3 November 12 earnings shows stronger-than-expected revenue trajectory
- Major customer announcement (hyperscaler or AI infrastructure player)
- Commercial production inflection hits early 2026 as guided
Technical Setup:
- Breakout above $9.00 immediate ceiling triggers gamma squeeze toward $10
- Massive 42:1 call/put gamma ratio supports bullish momentum
- $10 strike has 52K LEAPS open interest creating magnetic pull
- April 2026 $12 calls ($770K bet) suggest extended targets
January 2027 LEAPS at $10 strike deliver 50%+ gains, April 2026 $12 calls could 3-5x
π Base Case (45% chance)
Target: $8.50-9.50 consolidation
Catalysts:
- Consolidates between $8.00-8.50 support and $9.00 resistance through Q4 2025
- Steady progress on manufacturing partnerships (Foxconn, Globetronics, NationGate)
- Q3 earnings in-line with $400K revenue estimate
- Commercial inflection delayed to mid-2026 rather than early 2026
Technical Setup:
- Strong support at $8.00 (2.63M gamma) and $8.50 (0.04M gamma) provides floor
- Resistance at $9.00 (0.77M gamma) caps near-term upside
- Range-bound trading allows theta decay on short-dated calls
- LEAPS maintain value with production timeline still on track
October calls expire worthless, April 2026 calls modestly profitable above $9, January 2027 LEAPS hold value
π° Bear Case (15% chance)
Target: $7.50-8.00 retest
Catalysts:
- Production delays or technical issues in Malaysian manufacturing ramp
- Customer order pushouts extending revenue timeline beyond 2026
- Broader tech correction impacts small-cap growth stocks
- Capital raise dilution concerns despite $150M+ cash position
Technical Setup:
- Support at $8.00 (2.63M gamma) should hold on first test
- Deeper support at $7.50 provides safety net
- Would require significant negative catalyst to break below $7.50
- Bullish gamma bias limits downside severity
Near-term calls expire worthless, April 2026 calls lose 50%+, but LEAPS still viable for 2026 recovery
Strong gamma support at $7.50 and $7.00 limits significant downside
π‘ Trading Ideas
π‘οΈ Conservative: Support Zone Entry
Play: Buy shares at current levels with stop below gamma support
Enter POET shares at $8.50-8.77
Entry: Current price $8.77 or dip to $8.50 support (0.04M gamma floor)
Stop Loss: $7.90 (below $8.00 support with 2.63M gamma)
Target: $9.50-10.00 (gamma resistance levels)
Risk/Reward: 1:2.5 ratio
Why this works:
- Strong gamma support at $8.50 (immediate) and $8.00 (major 2.63M level)
- Fresh $75M capital raise provides 2+ year runway
- Positioned ahead of Q3 November 12 earnings catalyst
- Bullish 42:1 call/put gamma ratio limits downside
βοΈ Balanced: Pre-Earnings Call Spread
Play: Target $9.00 gamma breakout with defined risk
Buy $8 calls, sell $9 calls for October or November expiration
Cost: ~$0.50-0.70 net debit
Max Profit: $0.30-0.50 (50-100% return)
Breakeven: $8.50-8.70 (near current support)
Why this works:
- Targets $9.00 immediate gamma resistance (0.77M level)
- Q3 earnings November 12 provides near-term catalyst
- Defined risk with limited capital outlay
- Follows the $326K institutional flow at $8 strike
- If breaks $9, opens path to $10 LEAPS target
π Aggressive: Follow the $1.93M LEAPS Bet
Play: Buy January 2027 $10 calls for multi-year breakout
Buy $10 calls for ~$1.60-1.75
Entry: $1.60-1.75 premium (current ask ~$1.75)
Breakeven: $11.60-11.75 by January 2027
Target: $15+ on successful production ramp
Time Value: 15+ months for commercial inflection
Why this works:
- Matches the $1.93M institutional LEAPS positioning (52K open interest)
- Targets exact $10 gamma wall (7.10M resistance) where breakout accelerates
- Gives full 2026 for production ramp to early commercial revenue
- Small position risk for asymmetric upside in AI infrastructure boom
- If hits $15 by 2027, LEAPS deliver 200%+ returns
β οΈ Risk Factors
- Execution risk: Production scaling challenges or delays in Malaysian cleanroom operations could disrupt 2026 timeline
- Pre-revenue stage: Despite initial production order, meaningful revenue generation remains uncertain - company posted $17.3M net loss in Q2 2025
- High valuation: Trading at significant premium to revenue with price-to-sales ratio of 1,457x reflecting growth expectations
- Technology adoption: Market acceptance of optical interposer platform versus established photonics solutions from Broadcom and Lumentum
- Customer concentration: Heavy dependence on successful commercialization with limited customer base creates binary outcomes
- Dilution concerns: Company has raised over $100M in equity in past 15 months, though latest raise was at premium prices
- Small-cap volatility: Low liquidity and $578M market cap amplifies price swings on news
π The Bottom Line
Real talk: POET Technologies represents a high-risk, high-reward play on the AI infrastructure buildout. The $3M+ in options activity - particularly the concentration in 2027 LEAPS at $10 - signals institutional conviction that this company will successfully transition to commercial production and capture meaningful market share in optical interconnects.
If you own POET:
- Hold through Q3 earnings on November 12 for production update clarity
- Consider selling covered calls at $10 strike to collect premium while LEAPS holders accumulate
- Stop loss below $8.00 gamma support (2.63M level) protects against major disappointment
If you're watching:
- Best entry: Dip to $8.00-8.50 gamma support zone offers 1:2.5 risk-reward
- Key level: Break above $9.00 (0.77M gamma resistance) confirms bullish momentum
- Catalyst timing: Q3 earnings November 12, production shipping early 2026
If you're bullish on AI infrastructure:
- Follow the $1.93M LEAPS bet at $10 strike for patient capital approach
- The 52K open interest shows institutional conviction in multi-year growth
- Risk 1-2% of portfolio on this speculative AI infrastructure play
Mark your calendar: Q3 earnings November 12 will determine if the $10 LEAPS target is realistic or if production delays push timeline. The $75M capital raise completed today removes near-term funding risk and shows institutional confidence at premium prices ($5.50 per share with warrants at C$9.78).
Disclaimer: Options trading involves substantial risk and is not suitable for all investors. This analysis is for educational purposes only and not financial advice. Past performance doesn't guarantee future results. POET is a small-cap, pre-revenue company with significant execution risk.
About POET Technologies: POET is a semiconductor company pioneering optical interposer technology for AI infrastructure and hyperscale data centers with a $578.8M market cap and 90 employees.